Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 6;73(11):e4058-e4063.
doi: 10.1093/cid/ciaa1792.

Long COVID in the Faroe Islands: A Longitudinal Study Among Nonhospitalized Patients

Maria Skaalum Petersen  1   2 , Marnar Fríðheim Kristiansen  1   3   4 , Katrin Dahl Hanusson  2 , Marjun Eivindardóttir Danielsen  2   4 , Bjarni Á Steig  3   4 , Shahin Gaini  3   5   6 , Marin Strøm  1   7 , Pál Weihe  1   2
Affiliations

Long COVID in the Faroe Islands: A Longitudinal Study Among Nonhospitalized Patients

Maria Skaalum Petersen et al. Clin Infect Dis. .

Abstract

Background: Little is known about long-term recovery from coronavirus disease 2019 (COVID-19) disease, especially in nonhospitalized individuals. In this longitudinal study we present symptoms registered during the acute phase as well as long COVID (ie, long-lasting COVID-19 symptoms) in patients from the Faroe Islands.

Methods: All consecutive patients with confirmed reverse transcription-polymerase chain reaction testing from April to June 2020 were invited to participate in this study for the assessment of long COVID. Demographic and clinical characteristics and self-reported acute and persistent symptoms were assessed using a standardized detailed questionnaire administered at enrollment and at repeated phone interviews in the period 22 April to 16 August.

Results: Of the 180 participants (96.3% of the 187 eligible COVID-19 patients), 53.1% reported persistence of at least 1 symptom after a mean of 125 days after symptoms onset, 33.0% reported 1 or 2 symptoms, and 20.1% reported 3 or more symptoms. At the last follow-up, 46.9% were asymptomatic compared with 4.4% during the acute phase. The most prevalent persistent symptoms were fatigue, loss of smell and taste, and arthralgias.

Conclusions: Our results show that it might take months for symptoms to resolve, even among nonhospitalized persons with mild illness course in the acute phase. Continued monitoring for long COVID is needed.

Keywords: COVID-19; Faroe Islands; longitudinal study; persistent symptoms.

PubMed Disclaimer

Similar articles

  • Prevalence of long COVID in a national cohort: longitudinal measures from disease onset until 8 months' follow-up.
    Petersen MS, Kristiansen MF, Hanusson KD, Foldbo BM, Danielsen ME, Á Steig B, Gaini S, Strøm M, Weihe P. Petersen MS, et al. Int J Infect Dis. 2022 Sep;122:437-441. doi: 10.1016/j.ijid.2022.06.031. Epub 2022 Jun 23. Int J Infect Dis. 2022. PMID: 35753603 Free PMC article.
  • Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.
    Global Burden of Disease Long COVID Collaborators; Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, Ballouz T, Blyuss O, Bobkova P, Bonsel G, Borzakova S, Buonsenso D, Butnaru D, Carter A, Chu H, De Rose C, Diab MM, Ekbom E, El Tantawi M, Fomin V, Frithiof R, Gamirova A, Glybochko PV, Haagsma JA, Haghjooy Javanmard S, Hamilton EB, Harris G, Heijenbrok-Kal MH, Helbok R, Hellemons ME, Hillus D, Huijts SM, Hultström M, Jassat W, Kurth F, Larsson IM, Lipcsey M, Liu C, Loflin CD, Malinovschi A, Mao W, Mazankova L, McCulloch D, Menges D, Mohammadifard N, Munblit D, Nekliudov NA, Ogbuoji O, Osmanov IM, Peñalvo JL, Petersen MS, Puhan MA, Rahman M, Rass V, Reinig N, Ribbers GM, Ricchiuto A, Rubertsson S, Samitova E, Sarrafzadegan N, Shikhaleva A, Simpson KE, Sinatti D, Soriano JB, Spiridonova E, Steinbeis F, Svistunov AA, Valentini P, van de Water BJ, van den Berg-Emons R, Wallin E, Witzenrath M, Wu Y, Xu H, Zoller T, Adolph C, Albright J, Amlag JO, Aravkin AY, Bang-Jensen BL, Bisignano C, Castellano R, Castro E, Chakrabarti S, Collins JK, Dai X, Daoud F, Dapper C, Deen A, Duncan BB, Erickson M, Ewald SB, Ferrari AJ, Flaxman AD, Fullman N, Gamkrelidze A, Giles JR, Guo G, Hay SI, … See abstract for full author list ➔ Global Burden of Disease Long COVID Collaborators, et al. JAMA. 2022 Oct 25;328(16):1604-1615. doi: 10.1001/jama.2022.18931. JAMA. 2022. PMID: 36215063 Free PMC article.
  • Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
    Fernández-de-Las-Peñas C, Rodríguez-Jiménez J, Cancela-Cilleruelo I, Guerrero-Peral A, Martín-Guerrero JD, García-Azorín D, Cornejo-Mazzuchelli A, Hernández-Barrera V, Pellicer-Valero OJ. Fernández-de-Las-Peñas C, et al. JAMA Netw Open. 2022 Nov 1;5(11):e2242106. doi: 10.1001/jamanetworkopen.2022.42106. JAMA Netw Open. 2022. PMID: 36378309 Free PMC article.
  • Clinical patterns of somatic symptoms in patients suffering from post-acute long COVID: a systematic review.
    Nguyen NN, Hoang VT, Dao TL, Dudouet P, Eldin C, Gautret P. Nguyen NN, et al. Eur J Clin Microbiol Infect Dis. 2022 Apr;41(4):515-545. doi: 10.1007/s10096-022-04417-4. Epub 2022 Feb 10. Eur J Clin Microbiol Infect Dis. 2022. PMID: 35142947 Free PMC article. Review.
  • Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.
    Sukocheva OA, Maksoud R, Beeraka NM, Madhunapantula SV, Sinelnikov M, Nikolenko VN, Neganova ME, Klochkov SG, Amjad Kamal M, Staines DR, Marshall-Gradisnik S. Sukocheva OA, et al. J Adv Res. 2022 Sep;40:179-196. doi: 10.1016/j.jare.2021.11.013. Epub 2021 Nov 26. J Adv Res. 2022. PMID: 36100326 Free PMC article. Review.
See all similar articles

Cited by

See all "Cited by" articles

Publication types